Explore our new Cybersecurity Terms Glossary, explained by our experts.
Cybersecurity Terms Glossary
A biomedical device inventory is the authoritative record of every connected medical device in a healthcare organisation, with the software, network, and clinical detail needed to secure and support it.

What Is a Biomedical Device Inventory?
Ask a hospital IT team how many connected medical devices they have and the honest answer is usually a range. Infusion pumps, patient monitors, ventilators, imaging systems, laboratory analysers, dialysis machines, pneumatic tube controllers, and the workstations that drive them are bought by clinical engineering, maintained under vendor contracts, and often never appear in the IT asset database at all. A biomedical device inventory closes that gap: one record per device, owned jointly by clinical engineering and security, holding enough detail to answer a vulnerability question the same day it is asked.
WannaCry, on 12 May 2017, made the argument in a single afternoon. The National Audit Office found that at least 80 of 236 NHS trusts in England were disrupted, along with hundreds of GP practices, and that imaging equipment running embedded Windows was among the affected estate. Trusts could not immediately say which devices were exposed because no complete list existed.
The vulnerability research that followed reinforced the point. URGENT/11 in 2019 affected the VxWorks TCP/IP stack used in patient monitors and infusion systems; Ripple20 in 2020 did the same for the Treck stack; PwnedPiper in 2021 covered pneumatic tube station controllers installed in a large share of major hospitals. Each disclosure asked the same question, and each time the answer depended on whether a usable inventory existed.
A list of serial numbers is a maintenance record, not a security inventory. The fields that make it useful are these.
Active scanning of a clinical network is a genuine patient safety risk. Infusion pumps and analysers have been known to fault or reboot when probed with ordinary vulnerability scanner traffic, which is why healthcare has standardised on passive discovery: a mirrored port or network tap feeding a tool that identifies devices from the traffic they already generate, including DICOM and HL7 conversations. Passive discovery gets you perhaps eighty per cent of the estate quickly and safely.
The remainder comes from reconciliation. Compare the passive view against the clinical engineering maintenance system, the procurement records, and the vendor contract list, then walk the wards for devices that connect only intermittently. Ownership must be explicit: clinical engineering keeps the device record accurate, security keeps the vulnerability and exposure view accurate, and one named person signs off the reconciliation each quarter.
Medical devices placed on the UK market are regulated by the MHRA under the UK Medical Devices Regulations 2002 as amended, and the MHRA has published guidance on cybersecurity expectations for manufacturers across the device lifecycle. That obligation sits with the manufacturer. The operator’s duties come from elsewhere: NHS organisations in England are designated under the Network and Information Systems Regulations 2018 with the Department of Health and Social Care as competent authority, must complete the Data Security and Protection Toolkit annually, and hold asset management obligations under the Cyber Assessment Framework that an incomplete device inventory will not satisfy. Patient data on those devices is personal data of a special category under UK GDPR, with the ICO as regulator.
Turkish hospitals sit under a different pairing: the Ministry of Health’s health information security rules and the KVKK regime for health data, with device market access controlled by the Turkish Medicines and Medical Devices Agency. The inventory itself is the same engineering job, but the evidence you present and the authority you report an incident to both change, which matters for groups running hospitals in both countries.
At Privia Security, we assess connected clinical estates and test the devices and gateways within them through our IoT penetration testing work, starting from the inventory rather than assuming one exists.
Because some medical devices fault, reboot, or produce incorrect readings when scanned. Embedded network stacks in older equipment were never tested against scanner traffic, and the consequence can reach the patient. Healthcare organisations use passive discovery from mirrored traffic as the default, reserving active techniques for isolated test environments or for devices the manufacturer has confirmed will tolerate them.
The Manufacturer Disclosure Statement for Medical Device Security, a standardised questionnaire in which a manufacturer declares the security characteristics of a device: whether it stores patient data, what authentication it supports, how it is patched, what network services it exposes, and what third-party software it contains. Request it during procurement, because obtaining one after installation is considerably harder.
Rarely on the same timetable. Manufacturers often have to validate a patch before the device may be updated, and applying an unvalidated change can affect the device’s regulatory status and its support contract. The practical approach is compensating controls, meaning network isolation, strict access control, and monitoring, while the manufacturer’s validated update makes its way through the release process.
Both, with clearly split responsibilities. Clinical engineering owns device identity, location, maintenance status, and the relationship with the manufacturer. Security owns network exposure, vulnerability status, and segmentation decisions. A quarterly reconciliation signed off by a named owner keeps the two views aligned, and without that explicit arrangement the record drifts within months.
You May Be Interested In These
We use a few cookies that are needed to make this website work, and they are always on. We would also like to set analytics cookies, to see which pages are useful; functional cookies, so that our live chat works; and advertising cookies, to measure our campaigns. We will not set any of those until you say yes, and you can change your mind at any time from the Cookie Settings link in the footer.
Choose the cookies you are happy for us to use. Strictly necessary cookies are always on; everything else is off until you turn it on.
These cookies keep the website working: they hold your security checks, your form submissions and the choice you make here. The site cannot run without them, so they are always on.
These let our live chat open and remember your conversation, and let the newsletter sign-up work. Switch them off and the chat window will not appear.
These tell us which pages are read and how people find us, so that we can improve the site. The reports are about groups of visitors, never about you personally.
These let us measure our advertising and show you our adverts on other websites, such as LinkedIn, Google and Meta. Switch them off and you will still see adverts, but they will be less relevant.